Efficacy of Adipose Stromal Cells-Enriched High-Density Fat Graft Combined with BTX-A for Raynaud’s Phenomenon: A Prospective Cohort Study
March 2025
in “
Arthritis Research & Therapy
”
The study investigates the efficacy of combining adipose stromal cells-enriched high-density fat graft (HDFG) with botulinum toxin type A (BTX-A) for treating Raynaud’s phenomenon (RP). The results indicate that this combination is a reliable and beneficial intervention, resulting in high patient satisfaction. The study supports the use of this combined treatment approach for improving symptoms in patients with RP.